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Abstract
Background: The RNA polymerase of influenza virus is a heterotrimeric complex of PB1, PB2 and PA subunits which
cooperate in the transcription and replication of the viral genome. Previous research has shown that the N-terminal region
of the PA subunit of influenza A/WSN/33 (H1N1) virus is involved in promoter binding.
Methodology/Principal Findings: Here we extend our studies of the influenza RNA polymerase to that of influenza strains
A/HongKong/156/97 (H5N1) and A/Vietnam/1194/04 (H5N1). Both H5N1 strains, originally isolated from patients in 1997
and 2004, showed significantly higher polymerase activity compared with two classical human strains, A/WSN/33 (H1N1)
and A/NT/60/68 (H3N2) in vitro. This increased polymerase activity correlated with enhanced promoter binding. The N-
terminal region of the PA subunit was the major determinant of this enhanced promoter activity.
Conclusions/Significance: Overall we suggest that the N-terminal region of the PA subunit of two recent H5N1 strains can
influence promoter binding and we speculate this may be a factor in their virulence.
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Introduction
Influenza A virus is a single-stranded, negative-sense RNA virus
with an 8 segmented genome, belonging to the family Orthomyx-
oviridae [1]. The segmented genome is transcribed and replicated
by a viral RNA-dependent RNA polymerase in infected cells [2].
Transcription requires a capped RNA primer which is ‘‘snatched’’
from RNA polymerase II transcripts in the host cell [3–4]. This
cap snatching is performed by a cap-dependent endonuclease
activity of the influenza RNA polymerase complex, generating
short, 9 to 17-nucleotide, capped RNA primers [5–7]. On the
other hand, replication is independent of a primer. A full-length
positive sense RNA (cRNA) is initially synthesized from viral RNA
(vRNA), and subsequently serves as a template for the synthesis of
full-length negative-sense vRNA [1–2,8].
The influenza virus RNA polymerase is a trimeric complex
comprising three different subunits - PB1, PB2 and PA [1–2].
Electron microscopy shows that it is very compact with no
apparent boundaries [9–11]. No high resolution structure of the
trimeric polymerase complex is available yet, although amino
acids 1–197 of the N-terminal region of PA subunit [13,14], amino
acids 257–716 of PA complexed with a short peptide at the N-
terminus of PB1 [12] and short regions of the structure of PB2
[15–16] are known. All three subunits are generally found to be
required for both transcription and replication [1,17], although
other reports disagree [18]. The PB1 subunit contains an SDD
motif which is directly involved in RNA chain elongation [2,19–
20]. The PB2 subunit is involved in cap-snatching and cap-binding
[1–2,21]. The PA subunit is involved in transcription and
replication as well as endonuclease activity, cap binding and
promoter binding [6,15,17,22–23]. Furthermore, the PA is known
to have, or induce, proteolytic activity [24–26], although the
significance of this function is not fully understood.
Influenza viruses of H5N1 subtype have been isolated in the
past from chickens [27] and turkeys [28] (e.g. A/chicken/
Scotland/59; A/turkey/England/91) but the current H5N1
isolates are believed to derive from geese in Guangdong Province,
China in 1996 [29]. They received little attention until virus
spread to humans in Hong Kong in May 1997, killing 6 of 18
infected people [30–33]. Since then this highly pathogenic avian
influenza virus of the H5N1 strain has been circulating worldwide
especially in Southeast Asia [34–36]. Although sporadic transmis-
sion from poultry to humans occasionally occurs, current avian
H5N1 strains are not adapted to efficient human-human
transmission [37]. It has been shown that avian-to-human
transmission is limited by the receptor binding properties of the
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PB2 subunit [40–41]. Nevertheless, the mechanism of transmission
from birds to human is not fully understood. In most cases, H5N1
subtypes are highly pathogenic in humans and cause death
(mortality ,60%) or severe disease compared to classical human
strains such as H3N2 and H1N1 [34,42]. Recently, the
contribution of RNA polymerase and nucleoprotein to pathogen-
esis of avian H5N1 influenza virus in chickens has been reported
[43–44]. However, the molecular mechanism of the pathogenicity
in chickens and in humans is still poorly understood.
In recent reports on the mechanism of genome replication, it
has been shown that point mutants in the N-terminal region of the
PA subunit of influenza A/WSN/33 virus can interfere with
cRNA promoter binding, suggesting that this region of PA is
involved, directly or indirectly, in regulating promoter binding
[6,22–23]. In order to extend these studies to more recently
isolated strains, the RNA polymerase of A/Hong Kong/156/97
(H5N1) and A/Vietnam/1194/04 (H5N1) were compared here
with one another and with the older, more classical strains of
different subtypes, i.e. A/WSN/33 (H1N1) and A/NT/60/68
(H3N2). We found that the PA subunit of both of the polymerases
of H5N1 subtype can substantially increase RNA polymerase
activity by enhancing promoter binding in vitro. Analysis of
chimeras of the PA subunit of A/HongKong/156/97 (H5N1) with
A/WSN/33 (H1N1) showed that N-terminal domain of PA of A/
HongKong/156/97 (H5N1) increased polymerase activity in
vitro. However, unexpectedly, this N-terminal region of the PA
of A/HongKong/156/97 (H5N1), when expressed as a ribonu-
cleoprotein hybrid with the PB1, PB2 polymerase and NP subunits
of A/WSN/33 virus, decreased transcription and/or replication in
two different, cell-based assays in vivo, presumably by inhibiting
promoter clearance in the initial stages of replication and/or
replication. Our data highlight the importance of the N-terminal
region of PA of more recent H5N1 strains in influencing viral
replication.
Results
Comparison of polymerase activity of H5N1 human
strains with classical H1N1 or H3N2 strains in vitro
In order to test if the RNA polymerases of human-isolated
H5N1 strains differed from the polymerase of classical strains, we
initially compared recombinant polymerase activities of 2 human-
isolated avian strains A/HongKong/156/97 (H5N1) [HK] and
A/Vietnam/1194/04 (H5N1) [VN] with 2 classical human strains
of different subtypes A/WSN/33 (H1N1) [WSN] and A/NT/60/
68 (H3N2) [NT] in vitro. Figure 1A shows the trimeric complex of
influenza polymerase, which was transiently expressed in human
293T cells and partially purified utilizing a TAP (tandem affinity
purification) tag on the C-terminus of the PB2 subunit (see
Materials and Methods). The migration of PB1 and PB2 subunits
were identical in each strain (Figure 1A). However, the PA subunit
migrated differently, as observed before [23]. After quantitation of
the yields of the PA subunits (see Materials and Methods),
polymerase preparations were normalized to a standard amount of
polymerase (Figure 1A) before testing enzymatic activity.
Initially, we performed an ApG-primed transcription assay [45]
and a globin mRNA-primed transcription assay [18] with a short
model vRNA promoter (see Materials and Methods). In both
assays (Figure 1B and C), both HK and VN H5N1 strains showed
significantly higher activity, ranging from 2 to 4 fold, than the
classical human strains (WSN and NT) tested. To confirm the
differences in polymerase activity observed with ApG and globin
mRNA primers, we subsequently performed an ApG synthesis
assay – a measure of replication initiation, using either a vRNA
(Figure 1D) or a cRNA (Figure 1E) promoter as a short model
template (see Materials and Methods). The two H5N1 strains
(Figure 1D and E) showed significantly higher activity (3–11 fold)
than the classical strains (Figure 1D and E, lanes 1 and 2),
especially with the model cRNA promoter (Figure 1E). Overall,
the four in vitro assays (Figure 1B–E) consistently showed that both
H5N1 strains isolated from humans demonstrated significantly
higher activities in model replication and transcription assays in
vitro than those of classical human strains.
Analysis of the contribution of the polymerase subunit to
polymerase activity in vitro
To determine which polymerase subunit(s) are required for the
increased activity of the H5N1 polymerase in vitro, we measured
polymerase activities derived from various artificial hybrid
polymerases. In these experiments, the hybrid trimeric complexes
consisted of one polymerase subunit from one or other of the
H5N1 polymerases and the other two subunits from either the
H1N1 or the H3N2 polymerases. In all cases the 3 polymerase
subunits (PB1, PB2 and PA) were visualized on 7.5% SDS-PAGE,
showing that these hybrids could form a functional complex
(results not shown). Figure 2A and B show the results from hybrids
of HK (H) with WSN (W). In both the ApG-primed (Figure 2A)
and globin mRNA-primed transcription assays (Figure 2B), the
hybrid formed from the PB1 subunit of HK showed no significant
difference in activity from a WSN wild-type trimeric complex
(Figure 2A and B compare lanes 1 and 3). By contrast, polymerase
activities were significantly higher than wild-type WSN in the
hybrid with the PA subunit of HK (Figure 2A and B, compare
lanes 1 and 2). The mean polymerase activity was also increased in
hybrids with the PB2 subunit of HK (Figure 2A and B, lane 4),
although there was no statistically significant difference between
these hybrids and the wild-type used (lane1). Overall, Figure 2A
and B suggested that PA and possibly the PB2 subunits of HK may
have contributed to the increased activity of the wild-type H5N1
polymerase seen in Figure 1B–E. It should be noted that position
627 of the PB2 subunit – known to be involved in host restriction
[41], of HK is E (avian-like) whereas that of VN is K (human-like)
- see Discussion.
To test if the results were specific to the HK-WSN hybrids
tested above or were more generally valid, we constructed a set of
different hybrid polymerases derived from the VN (H5N1) strain
(V) in a background of the NT (H3N2) strain (N). We then
compared the polymerase activity of these hybrids with the wild-
type NT strain in vitro (Figure 2C and D). In these polymerase
hybrids, only the PA subunit of VN increased activity compared to
the wild-type NT in both the ApG-primed transcription assay
(Figure 2C, compare lanes 1 and 2) and the globin-primed assay
(Figure 2D, compare lanes 1 and 2). There was no increase in
activity with the PB2 subunit (Figure 2C and D). In fact, there was
a slight and statistically significant decrease in activity in hybrids
containing the PB1 and PB2 subunits of VN in the ApG-primed
transcription assay (Figure 2C, compare lanes 3 and 4 with lane 1).
Taking the results of Figure 2A–D together, we conclude that the
PA subunit of the two H5N1 strains (HK and VN) tested has a
major influence in increasing the in vitro activity (Figure 1) of the
H5N1 polymerase, when compared to classical H1N1 or H3N2
strains (Figure 2A and B, lane 4), although the PB2 subunit of HK
may also have an effect - see Discussion.
Finally, to confirm the significance of the PA subunit of the
H5N1 strains as a determinant of polymerase activity in vitro, we
measured the activities of hybrids with PA derived from NT
(H3N2), HK (H5N1) and VN (H5N1) in a complex with the PB1
PA and Promoter Binding
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primed transcription) and Figure 2F (globin-primed transcription)
showed that both HK PA (Figure 2E and F, lane 3) and VN PA
(Figure 2E and F, lane 4) increased activity, whereas the PA
subunit of NT decreased activity (Figure 2E and F, lane 2)
compared to the wild-type WSN (lane 1). These results confirmed
that PA subunits of both HK and VN H5N1 strains were
responsible for increased polymerase activity in vitro. Thus the
effect of PA on polymerase activity seems to be shared by at least
these two H5N1 strains.
The PA subunit of the H5N1 strains tested enhanced
promoter binding
Because the increased polymerase activity of H5N1 viruses
(Figure 1) was observed in 4 independent assays, this suggested
that a shared property of these assays was likely to mediate the
effects. The replication and transcription assays of Figure 1 all
depend on promoter binding prior to RNA polymerization
suggesting that H5N1-derived polymerase might have enhanced
promoter binding. To test this hypothesis, binding of radiolabelled
promoter to various hybrid polymerases was assayed by UV cross-
linking (see Materials and Methods). The PA subunit of HK in a
WSN background enhanced binding to the model vRNA
promoter (Figure 3A) and both PA and PB2 subunits enhanced
binding to the model cRNA promoter (Figure 3B) when compared
with wild-type WSN, but PA showed the greater effect (2.5–7 fold
increase). In the case of the V-N hybrids, however, only the PA
subunit of VN increased promoter binding by 2.5–3 fold
(Figure 3C and D, compare lanes 1 and 2). To test whether the
PA subunit of H5N1 viruses is generally required to increase
promoter binding, we measured promoter binding of hybrids of all
PA subunits tested in a WSN backbone. Both HK PA (Figure 3E
and F, lane 3) and VN PA (Figure 3E and F, lane 4) significantly
increased vRNA (Figure 3C) and cRNA (Figure 3D) promoter
binding. The higher promoter binding activity of the PA-H hybrid
compared to the PA-V hybrid (Figure 3E and F) is consistent with
the higher activity of the HK compared to VT polymerase in
Figure 1. Overall, these promoter binding results were in
agreement with the in vitro transcription and replication assays
(Figure 1 and 2), suggesting that the increased polymerase activity
of the HK or VN H5N1 strains in vitro resulted from enhanced
promoter binding - see Discussion.
Dissection of regions within the PA subunit of A/Hong
Kong/156/97 (HK) important for enhanced polymerase
activity
In order to localize regions on the PA subunit, which might
control the increased activity of the H5N1 polymerase, chimeras of
HK PA and WSN PA (PA-W/H and PA-H/W) were constructed,
dividing PA roughly in half at position 407 (Figure 4A). For these
experiments, HK PA and WSN PA were selected, because the HK
PA subunit showed the highest activity in all polymerase assays
(Figure 1B–E) and because the PA subunit of WSN is an
extensively studied classical strain [6,17,23,46–47]. Figure 4B
Figure 1. Comparison of polymerase activities of two H5N1 strains and two classical human strains in vitro. (A) 7.5% SDS-PAGE of WSN
(W), NT (N), HK (H) and VN (V) partially purified polymerases analysed by silver staining. The positions of PB1, PB2-TAP and the variable positions of PA
are indicated. (B) ApG-primed transcription of W, N, H & V polymerases (see Materials and Methods). (C) Globin mRNA-primed transcription of W, N, H
& V polymerases (see Materials and Methods). (D) ApG synthesis with a model vRNA promoter and (E) with a model cRNA promoter of W, N, H & V
polymerases (see Materials and Methods). Relative activity is % activity relative to WSN (W) from at least 3 independent experiments. Inset square
panels in B–E show typical results. * and ** show statistical significance at p,0.05 and p,0.01, respectively, in a Student’s t-test.
doi:10.1371/journal.pone.0005473.g001
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HK (see PA-H), and the 2 chimeras (WSN/HK (PA-W/H) and
HK/WSN (PA-H/W)). Migration of the PA of both PA-W/H and
PA-H/W chimeras was intermediate between the PA subunits of
wild-type WSN (W) and wild-type HK (see PA-H). The
polymerase activities were increased with the PA-H/W chimeras,
compared to wild-type WSN, in both the ApG-primed transcrip-
tion assay (Figure 4C, lane 4) and the globin mRNA-primed
transcription assay (Figure 4D, lane 4), whereas the slight increase
in activity with the PA-W/H chimera (Figure 4D, lane 3) was only
marginally significant. In the promoter binding assay with either
the model vRNA (Figure 4E) or cRNA promoters (Figure 4F), the
HK/WSN (PA-H/W) chimera also showed strong promoter
binding (Figure 4E and F, lane 4) comparable to the wild-type HK
level (Figure 4E and F, lane 2). These results suggested that the N-
terminal 1–407 amino acid of the PA subunit of HK made a large
contribution to the increased polymerase activity by increasing
promoter binding. There may also be a smaller contribution of the
C-terminal region of the PA subunit of HK to vRNA promoter
binding, but this is less significant than the N-terminal region
(Figure 4E, lane 3).
Ribonucleoprotein (RNP) reconstitution of polymerase
activity in avian DF1 cells and human 293T cells in vivo
The in vitro assays described above would suggest that the N-
terminal region of the PA subunit of HK was responsible for
increased polymerase activity of HK polymerase mediated by
enhanced promoter binding. In order to test if similar results were
valid in vivo, RNP reconstitution assays [6,17,23] were performed
in avian DF1 and human 293T cells and the results were
compared. We initially tested the activity of wild type HK and
WSN polymerase reconstituted as RNP in avian DF1 (chicken
fibroblast) cells by expressing PB1, PB2, PA and NP with a vRNA
neuraminidase reporter (see Materials and Methods) and assayed
Figure 2. Comparison of activities of polymerase hybrids between H5N1 strains and classical human strains in vitro. (A) and (B) a WSN
(W) subunit was replaced with the corresponding HK (H) subunit as indicated in 1–4. (C) and (D) a NT (N) subunit was replaced with the
corresponding VN (V) subunit as indicated in 1–4. (E) and (F) The PA subunit of WSN (W) was replaced with either the PA of NT (PA-N), or HK (PA-H) or
VN (PA-V). The activity was analyzed by the ApG-primed transcription assay (in A, C and E) and by the globin mRNA-primed transcription assay (in B, D
and F). Relative activity is % activity relative to the WSN (W) polymerase from at least 3 independent experiments. Inset square panels show typical
gels. * and ** show statistical significance at p,0.05 and p,0.01, respectively, in a Student’s t-test.
doi:10.1371/journal.pone.0005473.g002
PA and Promoter Binding
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extension (Figure 5A). For expression in DF1 cells it was necessary
to use a reporter with a chicken Pol I promoter [48]. In DF1 cells
all 3 steady-state neuraminidase RNA levels (vRNA, cRNA and
mRNA) of the HK strain were similar to the WSN control
(Figure 5A, compare W and H), whereas in 293T cells the levels of
vRNA, cRNA and mRNA were all significantly less than that of
the WSN strain (Figure 5B, compare W and H). However, RNP
activity of the HK strain was approximately 50% of the WSN
activity (i.e. it was not completely restricted) in 293T cells despite
the presence of an avian-type Glu residue at position 627 of PB2 in
the HK strain, consistent with previous replication studies with
RNP of this same HK strain [49]. These results suggested that the
HK strain did not show a significantly enhanced replication and
transcription activity in vivo, in either chicken DF1 or human
293T cells, that might have been predicted from our in vitro
results.
To test if another H5N1 strain, derived from ducks, showed
similar trends to the HK H5N1 strain on reconstitution of RNP in
chicken DF1 or human 293T cells, we reconstituted RNP from A/
duck/Fujian/01/02 (H5N1) (FJ) with a neuraminidase vRNA
reporter in either chicken DF1 or human 293T cells. In chicken
DF1 cells that the mean steady-state levels of neuraminidase
vRNA, cRNA and mRNA of FJ were all about 50% higher than
Figure 3. UV cross-linking of model vRNA and cRNA promoters to hybrid polymerases. Purified and quantified polymerases were
incubated, in (A), (C) and (E), with
32P-labelled 39 strand of the vRNA promoter in the presence of the unlabelled 59 strand of the vRNA promoter, or in
(B), (D) and (F), with
32P -labelled 39 strand of the cRNA promoter in the presence of the unlabelled 59 strand of the cRNA promoter. (A), (B) Hybrids
between HK (H) and WSN (W), as indicated. (C), (D) Hybrids between VN (V) and NT (N), as indicated. (E), (F) WSN (W) polymerase was compared to
hybrid polymerases of the PA of NT (PA-N), HK (PA-H) or VN PA (PA-V) with PB1 and PB2 from WSN. Relative activity is % relative to WSN from at least
3 independent experiments. Inset square panels show typical gels. * and ** indicate statistically significant differences (from W or N) at p,0.05 and
p,0.01, respectively, in a Student’s t-test.
doi:10.1371/journal.pone.0005473.g003
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although these differences was statistically significant only at the
90% significance level (mRNA, p=0.05; vRNA, p=0.09; cRNA,
p=0.10). In contrast, the FJ strain showed significantly lower
levels of all 3 RNAs in 293T cells when compared with WSN
(Figure 5E, compare W and FJ). Thus reconstituted RNP of an
authentic avian strain of H5N1 had very similar properties, in both
DF1 cells and 293T cells, to the HK strain isolated from humans
(compare Figure 5A and D; compare Figure 5B and E).
Next, we tested the effect of the HK PA subunit alone in a
hybrid (PA-H) where the other polymerase subunits, PB1 and PB2,
were derived from WSN. This clearly showed that PA was
inhibitory to replication and transcription, compared to wild-type,
in both chicken DF1 and human 293T cells (Figure 5A and C). By
testing the previously constructed PA chimeras (Figure 4A), we
found that the N-terminal 1–407 region of PA (chimera PA-H/W)
(Figure 5A and C) was responsible for the decreased activity in
both cell types, although chimeras with the C-terminal half of PA
(PA-W/H) showed slightly increased activity in DF1 (Figure 5A),
but not in 293T cells (Figure 5B). Overall, these results showed
that the N-terminal region (1–407) of the HK PA subunit (PA-H/
W), when expressed as a RNP with PB1, PB2 and NP derived
from WSN, decreased transcription and/or replication activity in
both DF1 and 293T cells. This result suggested that the enhanced
promoter binding mediated by the N-terminal region of PA of HK
observed in vitro was detrimental to transcription and/or
replication in vivo, at least in DF1 and 293T cells.
Discussion
The aim of this study was to compare the RNA polymerase of 2
human-isolated avian H5N1 strains both with one another and
also with 2 classical human isolates of differing subtypes i.e. A/
WSN/33 (H1N1) and A/NT/60/68 (H3N2). One of the human-
isolated avian H5N1 strains was A/Hong Kong/156/97 isolated
in 1997, the other A/Vietnam/1194/04, isolated from Vietnam in
2004. These two strains were selected because the 1997 stain was
the index strain - the first human isolate of H5N1 [50] while the
2004 Vietnam strain was a well characterized, genetically distinct,
antigenic variant [51]. Moreover, A/Vietnam/1194/04 had
acquired the PB2 627K host range mutation generally character-
istic of mammalian viruses, whereas A/Hong Kong/156/97
retained PB2 627E characteristic of avian viruses [41]. After
cloning the polymerase genes from both H5N1 strains, we
expressed and partially purified recombinant, heterotrimeric
(PB1, PB2 and PA) polymerase in 293T cells. Unexpectedly, we
found that the polymerase of both the HK and VN H5N1 strains
had significantly higher transcription and replication activities in
vitro than the 2 classical human H1N1 and H3N2 subtypes
(Figure 1).
To investigate which subunit, or subunits, of the polymerase was
required for the increased activity in the H5N1 strains we
constructed inter-strain hybrids where we mixed and matched
subunits. Surprisingly, the only polymerase subunit in such hybrids
to show increased activity in both H5N1 polymerases, irrespective
Figure 4. Polymerase activity and UV cross-linking of hybrids containing PA chimeras. (A) Design of PA chimeras. PA-W/H contained the
N-terminal amino acids, 1–407 of WSN and C-terminal 408–716 of HK. PA-H/W contained the N-terminal amino acids, 1–407 of HK and C-terminal
408–716 of WSN. (B) 7.5% SDS-PAGE of WSN (W) polymerase and 3 hybrid polymerases with the PA subunit derived from HK (PA-H) or from chimeras,
PA-W/H and PA-H/W, analysed by silver staining. The positions of PB1, PB2-TAP and the variable position of the PA subunits are shown. (C) ApG-
primed transcription activity. (D) Globin mRNA-primed transcription activity. (E), (F) Promoter binding activity analyzed by UV cross-linking with the
model vRNA promoter (in E) or the cRNA promoter (in F). Relative activity is % relative to WSN (W) from 4 independent experiments. * and ** indicate
statistically significant differences from W at p,0.05 and p,0.01, respectively, in a Student’s t-test.
doi:10.1371/journal.pone.0005473.g004
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subunit (Figure 2). Significantly, we could convincingly attribute
the increased activity of the H5N1 derived polymerase, compared
to the WSN (H1N1) or NT-derived (H3N2) polymerase, to
increased binding to both a model vRNA and a cRNA promoter
(Figure 3).
Figure 5. RNP reconstitution assays in chicken DF1 cells and human 293T cells. mRNA, cRNA and vRNA levels were measured by
primer extension. (A) RNA levels of RNP derived from WSN (W), HK (H), or from the (PA-H) hybrid of WSN, or from 2 hybrids (PA-W/H or PA-H/W)
containing the PA chimeras, were compared in DF1 cells. (B) RNA levels of RNP derived from WSN (W) and HK (H) were compared in human 293T cells.
(C) RNA levels of RNP derived from PA-H, PA-W/H and PA-H/W were compared in 293T cells. (D) RNA levels of RNP derived from WSN (W) and Fujian
(F) in DF1 cells. (E) RNA levels of RNP derived from WSN (W) and Fujian (F) in 293T cells. In all experiments, activities are expressed as a % relative to
the wild-type WSN (W) from 3 independent experiments. Black, white and oblique lined columns show steady-state levels of mRNA, cRNA and vRNA,
respectively. * and ** show statistically significant differences from wild-type WSN (W) at p,0.05 and p,0.01 in a Student’s t-test. WSN NP was used
for WSN and HK strains, and FJ NP was used for the FJ strain.
doi:10.1371/journal.pone.0005473.g005
PA and Promoter Binding
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at position 627 and varied in sequence by 4% between the HK
and VN strains, was apparently strain-specific, i.e. different results
were obtained with the HK and VT PB2 subunits (Figure 2 and 3).
Surprisingly, the HK PB2 seemed to promote activity more than
the VT PB2, even although the VT strain has the PB2 627K
residue characteristic of human-adapted strains, whereas HK has
an E residue at this position characteristic of avian viruses. Our
results may reflect the unusually active replication activity of this
HK strain (see below). Further studies, however, are needed to
confirm the different properties of the PB2 subunit of the HK and
VN strains in our experiments, because the results might simply be
a reflection of the different background strains (WSN or NT) used
in the hybrids (Figure 2).
We subsequently focused on the PA subunit of HK because its
polymerase was the more active of the 2 H5N1 strains studied.
Analysis of chimeras between the N and C-terminal regions of the
PA subunit of the HK and WSN strains suggested that the N-
terminal region of the PA of the HK stain was the main
determinant of the increased activity in vitro (Figure 4). Interest-
ingly, it has been shown recently that the N-terminal region of the
PA subunit (1–197 a.a.) has an endonuclease active site [13]. This
observation is consistent with the involvement of the N-terminal
region of PA in promoter binding, as demonstrated here. There
was, however, a smaller effect with the chimera containing the C-
terminal region of the HK H5N1 strain suggesting that the C-
terminal region of PA may also be involved in increasing
polymerase activity, but to a more limited extent. Subsequent
attempts to characterize which amino acid(s) in the N-terminal
region of the PA subunit of the H5N1 strains were responsible for
the increased polymerase activity were inconclusive. We found
that P28, R57 and S65 - all 3 amino acids characteristic of the PA
subunit of both HK and VN, when introduced into the PA subunit
of WSN, increased ApG-primed transcription activity in vitro, but
this stimulation was not confirmed in other in vitro assays, e.g.
globin-primed transcription, ApG synthesis (results not shown).
Because S65 of the HK PA subunit encompassed a potential CKII
phosphorylation site [52] we also tested for phosphorylation of HK
PA, after in-gel trypsin digestion, by LC-MS/MS mass spectrom-
etry. Only the non-phosphorylated peptide, GESIIVESGDP-
NALLK, was detected suggesting that phosphorylation had not
occurred at this position 65 (underlined).
In order to test the effect of the PA subunit of the HK (H5N1)
strain in vivo, the activity of the RNA polymerase of HK was
studied in RNP reconstitution assays in both human 293T cells
and avian DF1 cells. A reduced activity of the HK polymerase,
which has a PB2 subunit with 627E, compared to WSN
polymerase, which has a PB2 subunit with 627K, in 293T cells
was initially expected. This expectation was based on the fact that
the HK polymerase is essentially an avian isolate and would be
expected to show host-restriction in human cells [41]. However,
recent studies [49] on the same, HK polymerase show that it
retains significant replication activity in 293T cells irrespective of
whether PB2 at position 627 is E (avian-like) or K (human-like)
residue. This suggested that the reduced activity of the HK RNP,
when compared with WSN, in 293T cells (Figure 5B) is not caused
by the 627E residue in PB2. Nevertheless, our results (Figure 5A)
showed that the HK strain failed to significantly enhance
polymerase activity in DF1 cells (although there was a slight
increase in the mean value), as might have been expected from the
increased promoter binding in vitro (Figure 3).
Further insight into the properties of the PA subunit of HK was
obtained by studying the effects of a hybrid (PA-H) of the PA
subunit of HK with the PB1 and PB2 subunits derived from WSN
in RNP reconstitution assays. In both DF1 and 293T cells, activity
of this hybrid was significantly reduced (Figure 5A and C).
Confirming this and providing further information, we found that
chimeras between the N-terminal region of the PA subunit of HK
with the C-terminal region derived from WSN (PA-H/W) also
markedly inhibited replication in both DF1 and 293T cells
(Figure 5A and C). Consistent with this finding, no inhibition was
observed with the reciprocal chimera (PA-W/H). This strongly
suggested that the N-terminal region of the PA of HK mediated
the reduction in RNP activity.
Although the N-terminal region of the PA of HK clearly
influences polymerase activity both in vitro and in vivo, the
question arises how this region stimulated polymerase activity in
vitro (Figures 1–4) yet inhibited activity in the particular in vivo
assays (Figure 5) used here? Binding of the influenza RNA
polymerase to the proposed promoter corkscrew structure, formed
by the 59 and 39 ends of all influenza RNA segments, is an initial
step obligatorily required for polymerase activity whether this
occurs in vitro or in vivo. Promoters thus define the site of
initiation, yet the polymerase must release (promoter clearance)
from the promoter because the promoter itself is transcribed.
Subsequently the initial transcript is elongated to form short
transcripts in the case of the in vitro assays (Figures 1–4) or longer
transcripts similar to those produced in vivo in our RNP
reconstitution assay (Figure 5). Differences between the in vivo
and in vitro assays suggest a possible explanation for the different
results obtained. The in vivo assay uses polymerase reconstituted
as RNP and requires promoter binding followed by promoter
clearance to allow initiation of transcription/replication and
efficient synthesis of long RNA transcripts, without polymerase
‘‘stalling’’ (or polymerase release) from the template causing
abortive transcripts. By contrast, the in vitro assays use free
polymerase and promoter binding and only very limited promoter
clearance, since only between 1 and 14 nucleotides are synthesized
in the various assays used here (see Materials and Methods). It
follows that a promoter that binds the polymerase efficiently in
vitro, might not necessarily enhance transcription and replication
in vivo, because promoter clearance might be impaired. In vivo, a
strong promoter could result in excessive ‘pausing’ of transcription
and replication leading to abortive initiation. Lower levels of
influenza-specific transcripts would then accumulate.
Another potential reason for differences between the in vivo and
in vitro assays is that non-viral, host factors, such as Pol II, MCM
and hCLE - all factors proposed to interact with the influenza
polymerase, might influence replication of ribonucleoprotein of
HK and WSN to different extents in vivo, whereas these factors
would be expected to be absent in the in vitro polymerase
preparations [53–55]. Finally, the 293T and DF1 cells used here,
might not reflect the properties of the virus during infection of the
respiratory tract in humans. Thus, tissue-specific host factors,
differing between normal cells (e.g. lung alveolar epithelia) of the
respiratory tract and the 293T and DF1 cells used here, might
significantly alter viral transcription and/or replication.
It might be argued that the differences observed here between the
invitroresults andtheinvivoresultsarenotrepresentativeof H5N1
strains in general. However we have found that recombinant
polymerase derived from an H5N1 duck strain (A/duck/Fujian/
01/02) showed similar enhanced activity in vitro in the 4 different
assays reported in Figure 1 (results not shown). Moreover in RNP
reconstitution experiments in DF1 and 293T cells in vivo, this
authentic avian strain has similar properties to the human-derived
HK strain studied in detail here (see Figure 5D and E). Thus it is
likelythatourresults- emphasizingthe roleofthe N-terminalregion
of PA, are representative of H5N1 strains in general.
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virus influences its virulence in mice [56]. A/HongKong/156/97
virus, used as a source of RNA for cloning here, had been passaged
in eggs - a procedure known to attenuate virulence, so it is
conceivable that the PB1, PB2 and PA clones isolated here derived
from attenuatedviruses. However, a comparison of the sequences of
our PB1, PB2 and PA clones showed an imperfect correlation with
mutations correlating with attenuation [56]. Thus PA had the
amino acid (gly) at residue 631 correlating with the high pathogenic
sequence. PB2 had the amino acid (asp) at residue701 characteristic
of the less pathogenic form. PB1 had 2 mutations (at amino-acids
residues 17 (ala) and 456 (tyr) characteristic of the less pathogenic
form) but a third at residue 711 (ser) was characteristic of the high
pathogenic form. Given that the correlation of nucleotide mutations
in the polymerase genes with pathogenicity was not investigated in
detail [56], it is premature to conclude that the results reported here
were influenced by passage history of the virus, although this still
remains a possibility.
Thuswe speculate thattheN-terminaldomainofthePAsubunitof
the HK strain identified here will have a role in virulence of H5N1
viruses, although this hypothesis would have to be directly tested by
constructing recombinant viruses by reverse genetics and testing such
viruses in mouse or ferret animal models. Although the importance of
PB2 in virulence is not in doubt [40–41], it is becoming increasingly
clear that virulence is multigenic and the role of PA cannot be
ignored. Thus, recently, amino acid 515 of PA has been implicated in
the virulence of an avian H5N1 strain in ducks [43]. The PA subunit
was also proposed to act synergistically with the PB2 subunit in
regulating activity of the A/Hong Kong/156/97 RNP complex in
human cells in culture [49]. Moreover an interaction between PB2
and PA was proposed based on early studies of genetic suppression in
temperature-sensitive, influenza vaccines [57].
In summary, a major aim of this study was to extend previous
work showing that the N-terminal region of PA in influenza A/
WSN/33 was multifunctional, and was involved in endonuclease
activity, cap binding and promoter binding [6,22–23], to H5N1
viruses. Here we have extended the previous studies of the PA
subunit of the RNA polymerase of influenza A/WSN/33 (H1N1)
to 2 more recently isolated strains, A/HongKong/156/97 (H5N1)
and A/Vietnam/1194/04 (H5N1), and have shown that both
these H5N1 strains possess dramatically higher polymerase activity
in vitro, as a result of enhanced promoter binding, than those of
the classical human strains (H1N1 and H3N2) tested. This
enhanced activity, in the case A/HongKong/156/97, was shown
to be mainly a function of the N-terminal region of the PA subunit.
Overall, our data confirmed the importance of the PA subunit of 2
recent H5N1 strains in influencing promoter binding of the RNA
polymerase. Potentially this enhanced promoter binding may be a
factor in the virulence of H5N1 viruses, although this hypothesis
remains to be tested in animal models.
Materials and Methods
Strains
RNA or cDNA clones isolated from the following influenza
strains were used: A/HongKong/156/97 (H5N1), A/Vietnam/
1194/04 (H5N1), A/duck/Fujian/01/02, A/WSN/33(H1N1) and
A/NT/60/68 (H3N2). Position 627 of the PB2 subunit in A/
HongKong/156/97 and A/duck/Fujian/01/02 is glutamic acid
(E); the PB2 subunits of the other strains have a lysine (K) at 627.
Plasmids
PB1, PB2, PA and NP-expressing plasmids of influenza virus A/
WSN/33 (H1N1) pcDNA-PB1, pcDNA-PB2, pcDNA-PA,
pcDNA NP, pcDNA-PB2-TAP and pcDNA-PA-TAP) have been
described [17,47,58]. Full-length A/NT/60/68 (H3N2) PB1, PB2
and PA sequences were PCR amplified from the pBR322 clones,
A/NT/60/68/2/62, A/NT/60/68/1 and A/NT/60/68/3/11
[accession numbers: J02138 (PB1), J02139 (PA) and J02140 (PB2)]
[59–61] and inserted into pcDNA3A [45] using KpnI and NotI
restriction sites generating pcDNA/60/PB1, pcDNA/60/PA,
pcDNA/60/PB2, pcDNA/60/PA-TAP and pcDNA/60/PB2-
TAP expression vectors. To construct expression vectors for A/
duck/Fujian/01/02 PB1, PB2 and PA and NP [accession
numbers: AY585483 (PB1), AY585504 (PB2) and AY5854625
(PA) and AY585420 (NP)] [62], full-length sequences were PCR
amplified from pBD clones [63]. PB1, PA and NP PCR products
were inserted into pcDNA3A using KpnI and NotI restriction sites
generating pcDNA-FJ/01/02-PB1, pcDNA-FJ/01/02-PA and
pcDNA-FJ/01/02-NP. PB2 was inserted into pcDNA3A and
pcDNA-PB2-TAP using HindIII and NotI restriction sites
generating pcDNA-FJ/01/02-PB2 and pcDNA-FJ/01/02-PB2-
TAP, respectively.
To construct PB1, PB2 and PA expression vectors of A/
HongKong/156/97(H5N1) [accession numbers: AF036362 (PB1),
AF046095 (PA) and AF046093 (PB2)] [32,49] and A/Vietnam/
1194/04(H5N1) [accession numbers: AY651664 (PB1), AY651610
(PA) and AY651718 (PB2)] [64], RT-PCR was performed with
Superscript II reverse transcriptase (Invitrogen) and Fusion
polymerase (Stratagene) with RNA isolated from virus grown in
embryonated chicken eggs. PCR fragments were inserted into
pCR2.1-TOPO (Invitrogen) by TA cloning, and the coding region
subcloned into pcDNA3A using KpnI and NotI sites, generating
pcDNA/156/PB1, pcDNA/156/PA, pcDNA/156/PB2,
pcDNA/156/PA-TAP, pcDNA/156/PB2-TAP, pcDNA/1194/
PB1, pcDNA/1194/PA, pcDNA/1194/PB2, pcDNA/1194/PA-
TAP and pcDNA/1194/PB2-TAP.
The A/Hong Kong/156/97 PB1 cDNA cloned here has 4
mutations at the following nucleotide positions (counting from the A
of the initiator ATG as nucleotide 1) compared to the sequence of
AF036362 (i) 318, GRA (ii) 355, ARG (iii) 1828, GRT (iv) 2276,
ARG, causing 2 coding changes at amino acid residues 119,
MetRVal and 610, GlyRCys. PB2 and PA nucleotide and amino
acid sequences of A/Hong Kong/156/97 were identical to the
databasesAF046093(PB2)and AF046095(PA).A/Vietnam/1194/
04 PB2 cDNA cloned here also two coding changes (H60D and
K189E) compared to the sequence of AY651718. The pPOLI-vNA
plasmid has been described previously [17]. The PRC425.vNA
plasmid was created by subcloning the EcoRI and BpuAI fragment
of the A/WSN/33NA gene of pPOLINA into pPRC425[48]. The
plasmid contains part of the sequence of the NA gene under the
control of a chicken Pol I promoter. To construct PA chimera
plasmids,theN-terminalhalfortheC-terminalhalfofWSNPAwas
amplified by PCR and inserted into pcDNA/156/PA at KpnI and
BamHI sites, or BamHI and NotI sites, generating pcDNA/WH/
PA and pcDNA/HW/PA, respectively. Point mutations in the
WSN PA gene were made by site directed mutagenesis [6,17,23]
and were confirmed by full sequencing of the gene. Primer
sequences are available upon request.
Preparation of partially purified TAP-tagged polymerase
293T cells were transfected with the expression vectors
containing PB1, PB2-TAP and PA subunit of each strain. Crude
cell lysates were harvested 40 hours post-transfection and the
polymerase were partially purified by the tandem affinity
purification (TAP) method described previously [58]. The partially
purified polymerase was analyzed by 7.5% SDS-PAGE with silver
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amount of polymerase [23].
In vitro transcription assay
The quantitatively adjusted (see above), partially purified poly-
merase was used in the ApG-primed and globin mRNA-primed
transcription assay as described previously [17]. Briefly, 1.5 mlo f
TAP-purified polymerase was mixed with either 10 ng/ml globin
mRNA or 1 mM ApG as primer, 0.5 mMo ft h e5 9 strand of the
model vRNA promoter (59 AGUAGAAACAGGCC 39) (Dharma-
con), 0.5 mMo ft h e3 9 strand of the model vRNA (59 GGCCUG-
CUUUUGCU 39)( D h a r m a c o n ) ,5 m MM g C l 2, 1 mM DTT,
0.15 mM[ a
32P] GTP (3000 Ci/mmol, GE Healthcare), 1 mM
ATP,0.5 mMCTPand2 URNaseinhibitor(Promega)inareaction
volume of 3 ml. After 60 min incubation at 30uC, transcription
products were analyzed by 16% polyacrylamide gel containing 7 M
urea in Tris-Borate-EDTA (TBE) buffer. Transcripts were detected
by autoradiography and quantitated by phosphorimaging.
In vitro replication assay
The dinucleotide initiation of replication assay was performed as
described previously [6,65–66], using adenosine instead of ATP.
Briefly, 1.5 ml of adjusted polymerase was mixed with 0.02 mM
[a
32P] GTP (3000 Ci/mmol), 5 mM MgCl2, 1 mM DTT, 3 U
RNase inhibitor, 1 mM adenosine and 1.75 mMe a c ho ft h e5 9 and
39 strands of a model vRNA or model cRNA promoter in a 3 ml
reaction volume. After 16 hours at 30uC, the ApG products were
analyzed by 25% PAGE in 6 M urea in TBE buffer. ApG was
detected by autoradiography and quantitated by phosphorimaging.
UV cross-linking
UV cross-linking to model vRNA and cRNA promoters was
performed as described previously [6,17,23]. Briefly, 2.5 mlo f
quantitatively adjusted polymerase [23] in the presence of 0.25
pmol (50,000 dpm) [c
32P]-labelled 39 end of the vRNA promoter
and 2 pmol of unlabelled 59 end of vRNA promoter in a 5 ml
reactioncontaining10 mMHEPES(pH 7.5),100 mMKCl,2 mM
MgCl2, 0.5 mMEGTA,1 mMDTT,10%glycerol and 8 U RNase
inhibitor (Promega) was incubated at 30uC for 30 min. Reactions
were then UV irradiated (254 nm) and the cross-linked products
separated by 7.5% SDS-PAGE. Cross-linking was performed with
the model cRNA promoter by replacing the [a
32P]-labelled 39 end
of the vRNA promoter with approximately 0.25 pmol (50,000 dpm)
[a
32P]-labelled 39 end of the cRNA promoter (59 GGCCUU-
GUUUCUACU 39) (Dharmacon) and replacing the unlabelled 59
end of the vRNA promoter with 2 pmol of the unlabelled 59 end of
the cRNA promoter (59 AGCAAAAGCAGGCC 39) (Dharmacon).
The products were detected by autoradiography and quantitated by
phosphorimaging.
RNA isolation and primer extension assay
293T cells were transfected with expression vectors of PB1, PB2
and PA subunit of each strains (WSN, NT, HK and VN), pcDNA-
NP (WSN) and pPOLI-vNA (WSN). Subconfluent monolayers of
DF1 cells in DMEM medium supplemented with 10% FCS, in
60 mm dishes were transfected with Lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer. Briefly, 2 mg each of
pcDNA-PB1, pcDNA-PB2, pcDNA-NP, pPRC425.vNA plasmids
and 2 mg of PA plasmid of each strains (WSN, HK or mutant)
were diluted with 150 ml OPTI-MEM (Invitrogen). This solution
was then mixed with 20 ml of Lipofectamine 2000 reagent
(Invitrogen) previously diluted in 100 ml OPTI-MEM. 24 h. later
total cell RNA was isolated using TRIzol reagent (Invitrogen).
RNA was then analyzed in a primer extension assay using three
primers-one for vRNA, one for mRNA and cRNA, one for 5S
rRNA as an internal control [6,17,23]. Transcripts were visualized
by 6% polyacrylamide gel containing 7 M urea in TBE buffer and
quantitated by autoradiography and phosphorimaging.
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